Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

505

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

July 31, 2026

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone extended-release (ER)

Paliperidone extended-release (ER) tablets will be administered orally once daily at flexible doses ranging from 6 mg to 12 mg, based on the clinical judgment of the treating psychiatrist. The treatment duration is 12 weeks. Dose adjustments may be made throughout the study period depending on patient response and tolerability.

Trial Locations (1)

8200

Sher-E-Bangla Medical College Hospital, Barishal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ACI Pharmaceuticals

UNKNOWN

collaborator

US-Bangla Medical College Hospital

UNKNOWN

collaborator

Dr. M M Jalal Uddin

UNKNOWN

collaborator

Dr.Ahsan Aziz Sarkar

UNKNOWN

lead

Sher-E-Bangla Medical College

OTHER